-
Protein A/G Magnetic Beads for IVDD Studies
2026-09-16
Protein A/G Magnetic Beads provide a controlled affinity-capture strategy for validating the MAPK1/HMOX1–mitophagy–pyroptosis axis in intervertebral disc degeneration. This guide connects mechanistic findings from a recent Duhuo Jisheng decoction study with practical IP, Co-IP, and Ch-IP assay design.
-
BOP Reagent and Translational Prodrug Design
2026-09-16
A mechanistic and strategic guide to using BOP reagent in modular synthesis workflows inspired by carrier-free triterpene prodrugs for oral squamous cell carcinoma research, with clear boundaries between chemical enablement, biological validation, and translational readiness.
-
MK-2206 dihydrochloride for PI3K/Akt Assays
2026-09-15
Use MK-2206 dihydrochloride to connect Akt phosphorylation measurements with functional endpoints such as endothelial angiogenesis, viability, and cancer cell apoptosis. This workflow translates extracellular-vesicle findings in hepatocellular carcinoma into controlled pathway-perturbation experiments while separating biochemical potency from cellular dosing.
-
Protein A/G Magnetic Beads: Workflow Guide
2026-09-15
Protein A/G Magnetic Beads (SKU K1305) support antibody capture, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation from complex biological samples. They are intended for research workflows only, not diagnostic or medical use, and assay-specific binding, wash, and elution conditions should be validated experimentally.
-
NAD+ and AMPK: Reading Energy Stress Precisely
2026-09-14
Nicotinamide Adenine Dinucleotide (NAD+) is more than a redox metabolite: it can anchor a better strategy for interpreting AMPK, ULK1, and autophagy assays. This article connects NAD+ chemistry with a revised energy-stress model and practical experimental controls.
-
BCECF-AM for Intracellular pH Measurement
2026-09-14
BCECF-AM is a cell membrane permeable fluorescent probe for pH that becomes fluorescent BCECF after intracellular esterase hydrolysis. Its dual-excitation ratio using 490 nm and 440 nm excitation with 535 nm emission supports intracellular pH measurement, while plant autophagy research provides a relevant biological context for vacuolar acidification.
-
Influenza Hemagglutinin (HA) Peptide Workflow
2026-09-13
Turn HA-tagged constructs into a practical platform for selective detection, interaction mapping, and gentle immunoprecipitation elution. This workflow combines the high-purity Influenza Hemagglutinin (HA) Peptide with assay design lessons from exosome biology to improve recovery and interpretability.
-
BAY-826 and the Logic of Retinal Neurovascular Signaling
2026-09-12
A translational framework for using BAY-826 to interrogate angiopoietin, Tie-2, PI3K/Akt, and PEDF relationships in retinal neuron-survival models while separating validated biology from testable chemical hypotheses.
-
Clasto-Lactacystin β-lactone: Reading Degradation
2026-09-11
Clasto-Lactacystin β-lactone enables causal analysis of proteasome-dependent protein turnover rather than a simple endpoint measurement. This article connects its irreversible catalytic-site chemistry with viral RIPK3 degradation, assay design, and interpretation across cell biology and disease models.
-
Mecamylamine Hydrochloride in Gut-Brain Assays
2026-09-11
Mecamylamine hydrochloride gives researchers a practical pharmacological lever for testing whether acetylcholine-dependent signaling contributes to microbiota-linked neural phenotypes. This guide connects receptor-level assays with vagal, seizure, and neuropsychiatric workflows while emphasizing controls for its non-selective, brain-penetrant activity.
-
ML216: BLM Inhibition Meets Precision Oncology
2026-09-10
ML216 is a BLM helicase inhibitor for dissecting DNA repair, sister chromatid exchange, and genotype-selective tumor responses. This article explains how to connect BLM-focused assays with WRN–MSI cancer findings without confusing family-level evidence with target-specific conclusions.
-
3-Hydroxybutyrate (BHBA) in Neuroprotection
2026-09-10
3-Hydroxybutyrate (BHBA) is more than a ketone fuel: it is a metabolic signal, membrane-active metabolite, and class I HDAC inhibitor with potential relevance to ferroptosis and neuroprotection. This translational guide interprets stroke findings, defines validation workflows, positions BHBA against competing experimental strategies, and outlines how to use it as a mechanistically resolved research tool without overstating clinical evidence.
-
Intraarticular RTX for Osteoarthritic Pain
2026-09-09
The 2025 review evaluates intraarticular resiniferatoxin (RTX) as a high-potency TRPV1-directed intervention for osteoarthritic pain, integrating cellular, animal, canine, and early human evidence. Its central innovation is the use of localized TRPV1 activation to produce chemical inactivation of pain-sensing terminals, while highlighting dose, volume, administration route, and evidence maturity as critical translational variables.
-
EZ Cap™ EGFP mRNA: Practical Workflow
2026-09-09
EZ Cap™ EGFP mRNA provides a Cap 1 EGFP reporter mRNA input for testing delivery and expression in research systems. It is appropriate for controlled reporter assays, but the supplied information does not define a universal dose, cell type, delivery reagent, readout window, or expected performance outcome.
-
Annexin V-Cy5 Apoptosis Kit: A Better Readout
2026-09-08
The Annexin V-Cy5 Apoptosis Kit provides a rapid phosphatidylserine-based apoptosis assay for separating cell death from reversible lysosomal dysfunction. This guide develops an interpretation-first workflow for zebrafish microglia, combining flow cytometry apoptosis detection with fluorescence microscopy apoptosis analysis.